Literature DB >> 18347648

Home parenteral nutrition in advanced cancer: where are we?

Michelle L Mackenzie1, Leah Gramlich.   

Abstract

Patients with advanced and incurable cancer are a compelling group. Questions and comments that these individuals and their families have may include: "My daughter is expecting our first grandchild in 3 months--can I hope to see our new family member?"; "I can't keep any food down--is there anything I can do?"; "I am worried about losing so much weight, and feeling tired and weak--is there anything that may help?"; "Will I suffer a lot?". Indeed, the most pressing concerns of the patient relate to predictions about survival and control of symptoms. The clinician taking care of the patient may wonder what is the utility or futility of home parenteral nutrition (HPN) in both the individual with advanced cancer and in this population of patients at large, whether there is potential for harm such as increasing the burden of care or prolonging suffering, and how to optimize care and communication with the patient and their families. The nutrition scientist may want to know what the implications of advanced cancer are on nutrient requirements and utilization, whether there are markers that would differentiate between cachexia and simple starvation, and whether it is possible to use specific nutrients to modify the disease process. This review will provide insights into the understanding of the role of HPN in advanced cancer and opportunities for further investigation.

Entities:  

Mesh:

Year:  2008        PMID: 18347648     DOI: 10.1139/H07-151

Source DB:  PubMed          Journal:  Appl Physiol Nutr Metab        ISSN: 1715-5312            Impact factor:   2.665


  2 in total

1.  Functioning and health in patients with cancer on home-parenteral nutrition: a qualitative study.

Authors:  Martin Mueller; Stefanie Lohmann; Paul Thul; Arved Weimann; Eva Grill
Journal:  Health Qual Life Outcomes       Date:  2010-04-16       Impact factor: 3.186

Review 2.  The role of dietary nutrition in stomach cancer.

Authors:  Zoran Stojcev; Konrad Matysiak; Michal Duszewski; Tomasz Banasiewicz
Journal:  Contemp Oncol (Pozn)       Date:  2013-10-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.